相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons
Emily Cunningham Williams et al.
HUMAN MOLECULAR GENETICS (2014)
Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome
Jorge Castro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
Omar S. Khwaja et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Global Transcriptional and Translational Repression in Human-Embryonic-Stem-Cell-Derived Rett Syndrome Neurons
Yun Li et al.
CELL STEM CELL (2013)
Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome
Jorge Castro et al.
CURRENT OPINION IN NEUROLOGY (2013)
Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies
Rodney C. Samaco et al.
HUMAN MOLECULAR GENETICS (2013)
Activation of β2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats
Hou-Cheng Zhou et al.
LEARNING & MEMORY (2013)
A Descriptive Study of Adverse Events from Clenbuterol Misuse and Abuse for Weight Loss and Bodybuilding
Henry A. Spiller et al.
SUBSTANCE ABUSE (2013)
Recent progress in Rett syndrome and MECP2 dysfunction: assessment of potential treatment options
Christopher A. Chapleau et al.
FUTURE NEUROLOGY (2013)
Dual Regulation of miRNA Biogenesis Generates Target Specificity in Neurotrophin-Induced Protein Synthesis
Yu-Wen A. Huang et al.
CELL (2012)
Clenbuterol upregulates histone demethylase JHDM2a via the β2-adrenoceptor/cAMP/PKA/p-CREB signaling pathway
Yang Li et al.
CELLULAR SIGNALLING (2012)
Preclinical research in Rett syndrome: setting the foundation for translational success
David M. Katz et al.
DISEASE MODELS & MECHANISMS (2012)
An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model
Amutha Selvamani et al.
PLOS ONE (2012)
The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders
Nikolaos Mellios et al.
Frontiers in Psychiatry (2012)
Cholinergic hypofunction in MeCP2-308 mice: Beneficial neurobehavioural effects of neonatal choline supplementation
Laura Ricceri et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Elena Piskounova et al.
CELL (2011)
Epac-mediated cAMP-signalling in the mouse model of Rett Syndrome
S. L. Mironov et al.
NEUROPHARMACOLOGY (2011)
Pathogenesis of Lethal Cardiac Arrhythmias in Mecp2 Mutant Mice: Implication for Therapy in Rett Syndrome
Mark D. McCauley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Rett Syndrome: Revised Diagnostic Criteria and Nomenclature
Jeffrey L. Neul et al.
ANNALS OF NEUROLOGY (2010)
The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity
Lorna C. Gleeson et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Maria C. N. Marchetto et al.
CELL (2010)
Epilepsy and the natural history of Rett syndrome
D. G. Glaze et al.
NEUROLOGY (2010)
Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS
Takeshi Nishijima et al.
NEURON (2010)
Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome
Hao Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pathophysiology of Locus Ceruleus Neurons in a Mouse Model of Rett Syndrome
Praveen Taneja et al.
JOURNAL OF NEUROSCIENCE (2009)
Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities
Rodney C. Samaco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Daniela Tropea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches
Laura Ricceri et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome
Nupur Nag et al.
BRAIN RESEARCH (2008)
Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome -: Mecp2 gene dosage effects and BDNF expression
Mari Kondo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
β2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals
Brian P. Ramos et al.
NEUROBIOLOGY OF AGING (2008)
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA
Matthew E. Klein et al.
NATURE NEUROSCIENCE (2007)
The story of Rett syndrome: From clinic to neurobiology
Maria Chahrour et al.
NEURON (2007)
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome
Michael Ogier et al.
JOURNAL OF NEUROSCIENCE (2007)
MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production
Liron Abuhatzira et al.
EPIGENETICS (2007)
Behavioral and anatomical abnormalities in Mecp2 mutant mice:: A model for Rett syndrome
N. A. Stearns et al.
NEUROSCIENCE (2007)
Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome
Jean-Christophe Roux et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice
Georg M. Stettner et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice
JM Bissonnete et al.
PEDIATRIC RESEARCH (2006)
The disease progression mutant mice is affected of Mecp2 by the level of BDNF expression
QA Chang et al.
NEURON (2006)
Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice
JC Viemari et al.
JOURNAL OF NEUROSCIENCE (2005)
Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse
S Ide et al.
NEUROSCIENCE LETTERS (2005)
Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival
WH Zheng et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome
T Ishii et al.
BRAIN & DEVELOPMENT (2001)
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
J Guy et al.
NATURE GENETICS (2001)
Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol
W Fischer et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
分享论文
